Evidence map›Paper›PMID 21365731›Full record

ArticleChembiochem : a European journal of chemical biology2011

Peptide structure stabilization by membrane anchoring and its general applicability to the development of potent cell-permeable inhibitors.

Liv Johannessen, Jarrett Remsberg, Vadim Gaponenko, Kristie M Adams, Joseph J Barchi, Sergey G Tarasov, Sheng Jiang, Nadya I Tarasova

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Application ofMolecules (Basel, Switzerland) · 2019
    Article
  3. Position of lipidation influences anticancer activity of Smac analogs.Bioorganic & medicinal chemistry letters · 2019
    Article
  4. Article
  5. Article
  6. Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics.Advances in experimental medicine and biology · 2017
    Review
  7. Article
  8. Small cyclic agonists of iron regulatory hormone hepcidin.Bioorganic & medicinal chemistry letters · 2015
    Article
  9. Lipid-conjugated Smac analogues.Bioorganic & medicinal chemistry letters · 2015
    Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liv JohannessenCancer and Inflammation Program, Center for Cancer Research NCI-Frederick, Frederick, MD, 21702, USA.
Jarrett Remsberg
Vadim Gaponenko
Kristie M Adams
Joseph J Barchi
Sergey G Tarasov
Sheng Jiang
Nadya I Tarasova

Funding

CCR Biophysics Resource CoreZICBC010965 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TARASOV, SERGEY · 2009 to 2025
$10.5M
Inhibitors of protein-protein interactionsZIABC011306 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TARASOVA, NADYA · 2010 to 2025
$7.3M
Design of Therapeutic Peptide-Based NanoparticlesR01CA135341 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GAPONENKO, VADIM V · 2010 to 2014
$1.5M
Intramural NIH HHSNCI NIH HHS R01 CA135341NCI NIH HHS R01CA135341
6 · The paper itself

Abstract

Isolated protein motifs that are involved in interactions with their binding partners can be used to inhibit these interactions. However, peptides corresponding to protein fragments tend to have no defined secondary or tertiary structure in the absence of scaffolding by the rest of protein molecule. This results in low inhibitor potency. NMR and CD spectroscopy studies of lipopeptide inhibitors of the Hedgehog pathway revealed that membrane anchoring allows the cell membrane to function as a scaffold and facilitate the folding of short peptides. In addition, lipidation enhances cell permeability and increases the concentration of the compounds near the membrane, thus facilitating potent inhibition. The general applicability of this rational approach was further confirmed by the generation of selective antagonists of the insulin-like growth factor 1 receptor with GI(50) values in the nanomolar range. Lipopeptides corresponding to protein fragments were found to serve as potent and selective inhibitors of a number of nondruggable molecular targets.

Indexed as

Amino Acid SequenceCell Line, TumorCell Membrane PermeabilityCircular DichroismHedgehog ProteinsHumansMagnetic Resonance SpectroscopyMolecular Sequence DataPeptidesProtein Structure, TertiaryReceptor, IGF Type 1Hedgehog ProteinsPeptidesReceptor, IGF Type 1

Identifiers

PMID21365731
PMCPMC3493468

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.